Prestige Consumer Healthcare stock holds steady as investors watch valuation and growth
Published on 09/02/2026 at 07:42 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Prestige Consumer Healthcare Inc. (ISIN US74116D1037) stock is quoted at 51.78 USD on the New York Stock Exchange as of September 1, 2026, based on data from Yahoo Finance, implying a market capitalization of about 2.46 billion USD according to a valuation overview that places the company at a price-to-earnings multiple of 14.3x.
Valuation and recent price performance
According to the same Yahoo Finance snapshot dated September 1, 2026, Prestige Consumer Healthcare stock closed at 51.78 USD, down 1.32 percent on the day, with an after-hours indication around 51.13 USD, illustrating a modest pullback from its recent levels.
A separate valuation screen compiled by AIStockFinder lists Prestige Consumer Healthcare with a market capitalization of approximately 2.46 billion USD and a price-to-earnings ratio of 14.3x as of early September 2026, placing the stock in a mid-cap bracket that may appeal to investors looking for consumer health exposure at what appears to be a mid-teens earnings multiple.
More news and data on Prestige Consumer Healthcare
Further articles, regulatory disclosures and price data on Prestige Consumer Healthcare are available in the topic overview for this ISIN.
Consumer health portfolio in focus
Prestige Consumer Healthcare generates its revenue by marketing over-the-counter healthcare and personal care products, including well-known brands in categories such as digestive health, cold and allergy remedies and eye care, positioning the company in a defensive segment of the consumer sector where demand tends to be relatively resilient across economic cycles.
Stock level and investor view
With a share price of 51.78 USD as of the close on September 1, 2026, Prestige Consumer Healthcare stock reflects a valuation consistent with a market capitalization of about 2.46 billion USD and a price-to-earnings ratio of 14.3x, providing investors with a reference point for comparing the company to other consumer health peers.
Prestige Consumer Healthcare at a glance
- Company: Prestige Consumer Healthcare Inc.
- ISIN: US74116D1037
- Ticker: PBH
- Trading venue: NYSE
- Price (as of September 1, 2026): 51.78 USD
- Market capitalization: 2.46 billion USD (as of September 1, 2026)
- Sector / Industry: Consumer staples / Healthcare products
- Index membership: None of the major headline indices
